Annual Conference
Now Open! Call for Abstracts for the General Poster Session
NCCN welcomes original abstracts from investigators in general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.
The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, October 30, 2024, 11:59 PM ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2024.
Annual Conference Recorded Presentations
Experts from leading cancer centers came together to discuss updates to NCCN Guidelines®, the latest advances across several cancer types, and emerging issues in oncology.
CE credit is available for the oncology team. Explore 35 recorded educational sessions!
Record presentations from the 2024 NCCN Annual Conference are now available on NCCN Continuing Education Portal.
Save the Dates
NCCN 2025 Nursing Program: Advancing Oncology Nursing™
Thursday, March 27, 2025
New location! Caribe Royale Orlando, Orlando, FL
NCCN 2025 Annual Conference
Friday, March 28 – Sunday, March 30, 2025
New location! Caribe Royale Orlando, Orlando, FL
NCCN 2026 Annual Conference
Friday, March 27 – Sunday, March 29, 2026
Caribe Royale Orlando, Orlando, FL
Continuing Education
The NCCN 2024 Annual Conference included educational sessions highlighting significant updates and key issues for select NCCN Guidelines®, new and emerging therapies, controversies in oncology care, issues affecting oncology care, and strategies to address barriers to practice. This educational program was designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, PAs, pharmacists, and other health care professionals who manage patients with cancer.
This activity is supported by educational grants from:
- AstraZeneca
- Coherus BioSciences
- Dendreon Pharmaceuticals LLC.
- Eisai
- Exact Sciences
- Genentech, a member of the Roche Group
- GRAIL, LLC
- GSK
- Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- Lilly
- Menarini-Stemline
- Novartis
- Novocure
- Olympus Corporation of the Americas
- Sanofi
- Sirtex
- Taiho Oncology, Inc.
Supported by a grant from:
- Pfizer Inc.
This project has been made possible in part by a grant from:
- Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program
Supported by independent educational grants from:
- Daiichi Sankyo
- Incyte Corporation
- Merck & Co., Inc., Rahway, NJ, USA
Supported by independent medical education grants from:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc.
Supported by a medical education grant from:
- Karyopharm Therapeutics
Exhibit Hall
Conference attendees can view virtual exhibits in the Virtual Event Platform through June 2024.
For exhibitor opportunities, contact exhibits@nccn.org.
2024 Conference Sponsors
Platinum Level
Gold Level
Silver Level
Bronze Level
Patient Advocacy Pavilion Sponsors
Emerald
AstraZeneca
BeiGene
Coherus
Eisai
Incyte Corporation
Johnson & Johnson